Israel's BrainsWay reports 52% remission rate in real-world deep TMS for OCD — largest dataset

Summary

BrainsWay published real-world outcomes data from 847 OCD patients treated with their H7 deep TMS coil across 127 US clinical sites. The 52% Yale-Brown OCD Scale remission rate at 6 weeks is the largest real-world deep TMS OCD dataset published and substantially exceeds the 38% remission rate from the pivotal trial.